The Evolving Presentation of Renal Carcinoma in the United States: Trends From the Surveillance, Epidemiology, and End Results Program

Journal of Urology

Volumn 176, Issue 6, 2006, Pages 2397-2400

  Nguyen, Mike M ^a   Gill, Inderbir S ^a   Ellison, Lars M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

diagnosis; kidney; kidney neoplasms; mortality; SEER program

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SIZE; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; TUMOR VOLUME; UNITED STATES;

FEMALE; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; SURVIVAL ANALYSIS; UNITED STATES;

EID: 33751032350     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.07.144     Document Type: Article

References (11)

1. Chow W.H., Devesa S.S., Warren J.L., and Fraumeni Jr. J.F. Rising incidence of renal cell cancer in the United States. JAMA 281 (1999) 1628
2. Patard J.J., Tazi H., Bensalah K., Rodriguez A., Vincendeau S., Rioux-Leclercq N., et al. The changing evolution of renal tumours: a single center experience over a two-decade period. Eur Urol 45 (2004) 490
3. Giuliani L., Giberti C., Martorana G., and Rovida S. Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Urol 143 (1990) 168
4. Surveillance, Epidemiology, and End Results (SEER) Program Populations (1973-2002), National Cancer Institute, Department of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2005. Available at www.seer.cancer.gov/popdata. Accessed June 10, 2005
5. Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence-SEER 9 Regs Public-Use, Nov 2004 Sub (1973-2002), National Cancer Institute, Department of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2005 based on the November 2004 submission. Available at www.seer.cancer.gov. Accessed June 10, 2005
6. Sobin L.H., and Wittekind C. TNM Classification of Malignant Tumors. 6th ed. (2003), Wiley-Liss, New York pp. 193-195
7. Salama M.E., Guru K., Stricker H., Peterson E., Peabody J., Menon M., et al. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors. J Urol 173 (2005) 1492
8. Ficarra V., Novara G., Galfano A., Novella G., Schiavone D., and Artibani W. Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability?. Urology 63 (2004) 1050
9. Gill I.S. Minimally invasive nephron-sparing surgery. Urol Clin North Am 30 (2003) 551
10. McKiernan J., Simmons R., Katz J., and Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59 (2002) 816
11. Clark P.E., Schover L.R., Uzzo R.G., Hafez K.S., Rybicki L.A., and Novick A.C. Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissue. Urology 57 (2001) 252